ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,580, issued on March 3, was assigned to Vanderbilt University (Nashville, Tenn.).
"Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof" was invented by Sergey I Dikalov (Nashville, Tenn.) and Venkataraman Amarnath (Nashville, Tenn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The use of novel 2-hydroxybenzylamine derivatives as scavengers of isolevuglandins."
The patent was filed on Jan. 27, 2021, under Application No. 17/795,861.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=...